Upgrade to SI Premium - Free Trial

Axsome Therapeutics (AXSM) PT Raised to $259 at UBS

April 10, 2026 6:05 AM
(Updated - April 10, 2026 9:31 AM EDT)

UBS analyst Ashwani Verma raised the price target on Axsome Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change